GLG1 | Golgi glycoprotein 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
GPR108 | G protein-coupled receptor 108 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
HS6ST2 | Heparan sulfate 6-O-sulfotransferase 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HTATIP2 | HIV-1 Tat interactive protein 2, 30kDa | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IER3IP1 | Immediate early response 3-interacting protein 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Not detected |
IFI30 | Interferon, gamma-inducible protein 30 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IGFALS | Insulin-like growth factor binding protein, acid labile subunit | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
IL13RA1 | Interleukin 13 receptor, alpha 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IL6ST | Interleukin 6 signal transducer (gp130, oncostatin M receptor) | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IL7R | Interleukin 7 receptor | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ITGA3 | Integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ITGB1 | Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
KIAA0195 | KIAA0195 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
L1CAM | L1 cell adhesion molecule | CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LIFR | Leukemia inhibitory factor receptor alpha | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
LRCH3 | Leucine-rich repeats and calponin homology (CH) domain containing 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
LRP1 | Low density lipoprotein receptor-related protein 1 | Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
LRRC37B | Leucine rich repeat containing 37B | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
MANSC1 | MANSC domain containing 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
MCU | Mitochondrial calcium uniporter | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
MDFIC | MyoD family inhibitor domain containing | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
MET | Met proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
MIA3 | Melanoma inhibitory activity family, member 3 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
MINOS1-NBL1 | MINOS1-NBL1 readthrough | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NDUFB5 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5, 16kDa | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
NOS1AP | Nitric oxide synthase 1 (neuronal) adaptor protein | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NOTCH3 | Notch 3 | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
NPFFR2 | Neuropeptide FF receptor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
NT5E | 5'-nucleotidase, ecto (CD73) | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
OCLN | Occludin | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
PDIA6 | Protein disulfide isomerase family A, member 6 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
PODXL | Podocalyxin-like | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PQLC2 | PQ loop repeat containing 2 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
PTPRJ | Protein tyrosine phosphatase, receptor type, J | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
QSOX1 | Quiescin Q6 sulfhydryl oxidase 1 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
RMDN3 | Regulator of microtubule dynamics 3 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
RNF130 | Ring finger protein 130 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
RPN1 | Ribophorin I | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
RPN2 | Ribophorin II | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
SDC1 | Syndecan 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
SEC16A | SEC16 homolog A (S. cerevisiae) | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
SEMA4D | Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
SIGLEC10 | Sialic acid binding Ig-like lectin 10 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SLC15A3 | Solute carrier family 15 (oligopeptide transporter), member 3 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
SLC25A26 | Solute carrier family 25 (S-adenosylmethionine carrier), member 26 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
SLC39A14 | Solute carrier family 39 (zinc transporter), member 14 | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
SNX14 | Sorting nexin 14 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
TEX264 | Testis expressed 264 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
THOC3 | THO complex 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |